Irinotecan in the adjuvant treatment of colon cancer: is the story finished or does personalized therapy open new opportunities?

MeSH terms

• Antineoplastic Agents, Phytogenic / administration & dosage*
• Antineoplastic Agents, Phytogenic / adverse effects
• Antineoplastic Agents, Phytogenic / pharmacokinetics
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Camptothecin / administration & dosage
• Camptothecin / adverse effects
• Camptothecin / analogs & derivatives*
• Camptothecin / pharmacokinetics
• Clinical Trials, Phase III as Topic
• Colonic Neoplasms / drug therapy*
• Colonic Neoplasms / mortality
• Disease-Free Survival
• Humans
• Irinotecan
• Patient Selection
• Precision Medicine*
• Randomized Controlled Trials as Topic
• Survival Analysis
• Treatment Outcome